FDA Releases Tips for Animal Studies in Bone Grafting Devices
Published Date: 8/22/2025
Notice
Summary
The FDA just released clear advice for companies making dental bone grafting materials on how to do animal studies for their 510(k) submissions. This helps speed up reviews and makes sure everyone follows the same rules. If you’re in this business, get ready to save time and avoid costly mistakes!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
FDA Guidance for Dental Graft Devices
If you make dental bone grafting material devices, the FDA released final guidance on recommended animal study designs and the animal-study information to include in a Premarket Notification (510(k)) submission. The guidance may help manufacturers comply with some special controls and is intended to promote consistency and facilitate efficient review of those 510(k) submissions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
Previous / Next Documents
Previous: 2025-16136, Request for Nominations of Members To Serve on the Healthcare Advisory Committee
The Department of Health and Human Services is looking for awesome people to join a new Healthcare Advisory Committee. If you care about health and want to help shape important decisions, now’s your chance to apply! This is a great opportunity to make a difference, with nominations open for a limited time and no cost to join.
Next: 2025-16138, Yuba County Water Agency; Notice of Application for a Variance Under Article 33d Accepted for Filing, Soliciting Comments, Motions To Intervene, and Protests
The Yuba County Water Agency asked for a temporary change to how much water they release from their hydroelectric project on the Yuba River in California for 2026. This affects local rivers and nearby communities, and the public has until September 18, 2025, to share their thoughts or get involved. No big money changes are mentioned, but this tweak could impact river flow and the environment.